🤔 This week: TSLA Q3 earnings report - is now the right time to buy the EV giant?Explore TSLA Data

Hold or Sell? The APE, AXS, INJ Conundrum as Token Unlocks Approach

Published 01/17/2024, 03:17 PM
Updated 01/17/2024, 03:45 PM
Hold or Sell? The APE, AXS, INJ Conundrum as Token Unlocks Approach
XVS/USD
-
AXS/USD
-

  • APE could rise to $1.60 as the CMF jumped into the positive region.
  • AXS might continue moving between $7.93 and $7.97 in the short term.
  • Should bulls sustain the buying momentum, INJ might hit $45 again.

According to the Token Unlocks X handle, ApeCoin (APE), Axie Infinity (AXS), and Injective (INJ) have major unlocks this week. Coin Edition checked the Token Unlocks website and found that APE would unlock another 4.23% of its supply.

At press time, these tokens were worth $22.62 million. Like ApeCoin, Injective plans to unlock tokens worth $156.19 million, representing 4.33% of its supply. Lastly, AXS’ unlock was worth $27.37 million.

Most times, when projects release new tokens into circulation, the prices of the cryptocurrencies fall afterward. However, in some cases, it does not take long for the values to erase the losses. But what is the potential price prediction for APE, AXS, and INJ once these new unlocks are done?

ApeCoin (APE) Price Prediction

APE’s price as of this writing was $1.44, indicating a 7.58% increase in the last seven days. However, details from the 4-hour chart…

The post Hold or Sell? The APE, AXS, INJ Conundrum as Token Unlocks Approach appeared first on Coin Edition.

Read more on Coin Edition

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.